2025 年 6 月 13 日医麦客新闻 eMedClub News6 月 11 日晚,荣昌生物官微文章称,第 62 届欧洲肾脏病学会年会(ERA)期间,多位跨国医药公司 BD 经理主动接洽,围绕泰它西普的国际合作、技术授权等商业拓展方向展开深度交流。次日,正大天晴称,中国生物制药近期将有一笔标志性的重磅对外授权交易落地。荣昌生物正在与多家跨国公司洽谈 BD荣昌生物研发的泰它西普,是全球首个 B ...
Source Link2025 年 6 月 13 日医麦客新闻 eMedClub News6 月 11 日晚,荣昌生物官微文章称,第 62 届欧洲肾脏病学会年会(ERA)期间,多位跨国医药公司 BD 经理主动接洽,围绕泰它西普的国际合作、技术授权等商业拓展方向展开深度交流。次日,正大天晴称,中国生物制药近期将有一笔标志性的重磅对外授权交易落地。荣昌生物正在与多家跨国公司洽谈 BD荣昌生物研发的泰它西普,是全球首个 B ...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.